Johnson & Johnson has recalled at least 395 injection devices containing rheumatoid-arthritis drug Simponi in the U.S. and Germany, due to a potential defect that could result in an insufficient dose of the drug.
European health authorities warned Friday that the manufacturing snafu could cause a temporary shortage of the Simponi devices. As an alternative, patients are being advised to use prefilled syringes of Simponi. Get the full story »
